SCHEMBL25979225

SCHEMBL25979225

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3ccc(-c5cccc(N(c6ccccc6)c6ccc7ccccc7c6)c5)cc34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 2/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MMP12 P39900 1/20 0.33
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
CHEK2 O96017 1/20 0.32
HCRTR1 O43613 1/20 0.32
ANO1 Q5XXA6 1/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25975865 0.97 CYP1A2 (0.37) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL25978938 0.97 ALDH1A1 (0.36) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL25975863 0.97 ALDH1A1 (0.36) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL25979000 0.95 ALDH1A1 (0.36) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL25978941 0.95 ALDH1A1 (0.36) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL25979759 0.95 CYP1A2 (0.38) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL26415690 0.94 PGR (0.35) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL25978662 0.94 ALDH1A1 (0.37) ALDH1A1CYP1A2KMT2AKDM4EHSD17B10
SCHEMBL25978971 0.93 PLA2G2A (0.35) ALDH1A1KMT2AKDM4EMEN1MMP12
SCHEMBL26779128 0.93 PLA2G2A (0.35) ALDH1A1KMT2AKDM4EMEN1MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALDH1A1 9/4885CYP1A2 5/4885KMT2A 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.